Praxis Precision Medicines (PRAX) Treasury Shares (2019 - 2026)
Praxis Precision Medicines (PRAX) recorded quarterly Treasury Shares of $131802.0 in Q1 2026, down 74.46% quarter-over-quarter from $516119.0 in Q3 2025, and down 74.76% on a YoY basis from $522257.0 in Q1 2025.
Praxis Precision Medicines (PRAX) Treasury Shares (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Treasury Shares history runs 8 years deep, the most recent figure standing at $131802.0 for Q1 2026.
- In Q1 2026, Treasury Shares fell 74.76% year-over-year to $131802.0; the TTM figure through Mar 2026 stood at $131802.0 (down 74.76% YoY), while the FY2024 annual figure was $224473.0, up 376.13% from the prior year.
- Treasury Shares was $131802.0 for Q1 2026 at Praxis Precision Medicines, down from $516119.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $856287.0 in Q2 2022 to a low of $47145.0 in Q4 2023.
- Historically, Treasury Shares has averaged $435025.8 across 5 years, with a median of $515857.5 in 2025.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares plunged 88.74% in 2022, then surged 435.09% in 2025.
- A 5-year view of Treasury Shares shows it stood at $49565.0 in 2022, then retreated by 4.88% to $47145.0 in 2023, then soared by 376.13% to $224473.0 in 2024, then jumped by 129.92% to $516119.0 in 2025, then sank by 74.46% to $131802.0 in 2026.
- The last three Treasury Shares figures came in at $131802.0 (Q1 2026), $516119.0 (Q3 2025), and $515596.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Praxis Precision Medicines | 200.22 Mn | -586.65 Mn | - | 131,802.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 131,802.00 |
| Mar 31, 2026 | 131,802.00 |
| Sep 30, 2025 | 516,119.00 |
| Sep 30, 2025 | 516,119.00 |
| Jun 30, 2025 | 515,596.00 |
| Jun 30, 2025 | 515,596.00 |
| Mar 31, 2025 | 522,257.00 |
| Mar 31, 2025 | 522,257.00 |
| Dec 31, 2024 | 224,473.00 |
| Dec 31, 2024 | 224,473.00 |
| Sep 30, 2024 | 222,674.00 |
| Sep 30, 2024 | 222,674.00 |
| Jun 30, 2024 | 101,462.00 |
| Jun 30, 2024 | 101,462.00 |
| Mar 31, 2024 | 97,601.00 |
| Mar 31, 2024 | 97,601.00 |
| Dec 31, 2023 | 47,145.00 |
| Dec 31, 2023 | 47,145.00 |
| Sep 30, 2023 | 633,615.00 |
| Sep 30, 2023 | 633,615.00 |